In a first, Glenmark launches COVID-19 drug day after DCGI approval
NE BUSINESS BUREAU MUMBAI, JUNE 20 Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand ...
Tag: Favipiravir and Umifenovir
Glenmark to start another new Phase 3 clinical trial on a combination of 2 anti-viral drugs Favipiravir & Umifenovir
NE BUSINESS BUREAU MUMBAI, MAY 27 Glenmark Pharmaceuticals has announced, on Tuesday, a new randomized, open-label study to test the ...
